UZM.DR. ULVİ SAMADZADE

• İzmir Ekonomi Universitesi Medikal Point Hastanesi 2025 - Halen devam ediyor

• MS Araştırmaları Derneği
• Türk Nöroloji Derneği
• Europan Academy of Neurology
• The International Parkinson and Movement Disorder Society (MDS)

Uluslararası Dergilerde Yayımlanan Makaleler

• COVID-19 vaccine response in Neuromyelitis Optica SpectrumDisorder. BabaC.,KayaE.,OzcelikS.,OzdogarA.T.,SamadzadeU.,CevikS.,ÇalışkanC.,DoganY.,Ozakbas S. Clinicalneurology and neurosurgery,vol.238,no.238,pp.108152,2024 (SCI-Expanded)
• Three doses of COVID-19 vaccines inmultiple sclerosis patients treated with disease-modifying therapies. BabaC.,OzcelikS.,KayaE.,SamadzadaU.,OzdogarA.T.,CevikS.,DoganY.,Ozakbas S. Multiple sclerosis and related disorders,vol.68,pp.104119,2022 (SCI-Expanded)
• Whatmight the COVID-19 pandemic in regard to people with neuromyelitis optica spectrumdisorder teach us regarding the future? Baba C.,Yavas I.,SAMADZADE U.,ÖZDOĞAR A.T.,OZAKBAS S. ClinicalandExperimentalNeuroimmunology,vol.15,no.1,pp.40-44,2024 (Scopus)
• Is disease-modifying therapy use in multiple sclerosis a risk factor during the COVID-19 pandemic? A large cohort study Ozakbas S.,BabaC.,Yavas I.,SAMADZADEU.,ÖZDOĞARA.T. JournalofHealthPolicy andOutcomesResearch,vol.2024,no.1,pp.41-49,2024 (Scopus)
• Kaya E, Samadzade U, Zengin ES, Ozakbas S. Autoimmune thyroiditis and its impact on the clinical course of Multiple Sclerosis: A retrospective cohort study. Mult Scler Relat Disord. 2025 Mar;95:106341. doi: 10.1016/j.msard.2025.106341. Epub 2025 Feb 18. PMID: 39999593.

Kongre bildirileri

• Bladder dysfunction and associated factors in people with neuromyelitis optica spectrumdisorder SamadzadeU.,Yavaş I.,BabaC.,Özakbaş S. ECTRIMS2023,Milan, Italy,11 -13October 2023,pp.675
• Impact of Early Treatment Modification on Long-Term Outcomes in Treatment-Naive Multiple Sclerosis Patients: Adverse Reactions and Compliance Challenges Ulvi Samadzade, Cavid Baba Yasemin Şimşek4, Gözde Deniz Ünal, İrem Kara, Ozge Ertekin, Serkan Ozakbas Multiple Sclerosis JournalVolume 30, Issue 3_suppl: 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 18-20 September 2024, Copenhagen, Denmark
• Epilepsy Prevalence and Characteristics in Patients with Multiple Sclerosis: Implications for Disease Management Ergi Kaya, Ulvi Samadzade, Gözde Deniz Ünal, Ela Zengin, Serkan Ozakbas Multiple Sclerosis JournalVolume 30, Issue 3_suppl: 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 18-20 September 2024, Copenhagen, Denmark
• Determinants of PostpartumRelapse inMultiple Sclerosis: A Comprehensive Analysis of Demographic and Clinical Factors Alızada S.,SamadzadeU.,AygündüzYapıcıN.,KayaE.,ÖzdoğarA.T.,Ozakbas S. 40thCongress ofTheEuropeanCommit ee forTreatmentandResearch inMultiple Sclerosis (ECTRIMS), Kobenhavn,Denmark,18 -20 September 2024,vol.30,no.3
• Comparison of the objective and subjective cognitive fatigue during relapse and remission in individuals withmultiple sclerosis: preliminary results Ozakbas S.,YigitP.,Kara İ.,SamadzadeU.,ÖzdoğarA.T. 40thCongress ofTheEuropeanCommit ee forTreatmentandResearch inMultiple Sclerosis (ECTRIMS), Kobenhavn,Denmark,18 -20 September 2024,vol.30,no.3
• ,Alızada S.,SamadzadeU.,CevikS.,AygündüzYapıcıN.,SimsekY.,ZenginE.,Ozakbas S. 40thCongress of theEuropeanCommit ee forTreatmentandResearch inMultiple Sclerosis (ECTRIMS), Kobenhavn,Denmark,18 -20 September 2024,vol.30,no.3
• Immune response against SARS-CoV-2 vaccines in treatment-naivemultiple sclerosis patients Ozakbas S.,Baba C.,SAMADZADE U.,KAYA E.,ÖZÇELİK S.,ÖzdoğarA.T.,DOĞAN Y.,ÇEVİK S. 38thCongress of theEuropean-Commit ee-for-Treatment-and-Research-in-Multiple-Sclerosis,Amsterdam, Netherlands,26 -28October 2022,no.941,pp.776
• Baziller tepe sendromu: İki olgu sunumu Samadzade U.,Çiftçi L.,Fırat A. 59.ULUSALNÖROLOJİKONGRESİ,Antalya,Turkey,12 -18December 2023,pp.109
• LİTYUMİNTOKSİKASYONUNA BAĞLI OLDUĞUNU DÜŞÜNDÜĞÜMÜZ BİR ENSEFALOPATİ OLGUSU SamadzadeU.,YakaE. 58.Ulusal Nöroloji Kongresi, Antalya, Turkey,18 -24November 2022,pp.416
• AKUT SEREBRAL İSKEMİ İLE AKUTMYOKARD ENFARKTÜSÜ BİRLİKTELİĞİ SamadzadeU.,Suna Z.,ÖztürkV. 58.ULUSALNÖROLOJİKONGRESİ,Antalya,Turkey,18 -24November 2022,pp.304
• ANEVRİZMATİK SAK VE GERİ-DÖNÜŞÜMLÜ SEREBRAL VASOKONSTRUKSİYON SEDROMU BİRLİKTELİĞİ ULVİ SAMADZADE, SÜLEYMAN MEN, VESİLE ÖZTÜRK 19. Başağrısı Kış Okulu, Türk Nöroloji Derneği, İstanbul, Türkiye, 7-9 Nisan 2023. (Sözlü Sunum)
• Impact of Diagnosis and Treatment Timing on Long-Term Outcomes in Multiple Sclerosis: A Comprehensive Study Serkan Ozakbas, Ulvi Samadzade, İrem Kara, Gözde Deniz Ünal Multiple Sclerosis JournalVolume 30, Issue 3_suppl: 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 18-20 September 2024, Copenhagen, Denmark
• Natalizumab Treatment Outcomes and Safety Profile in Women with Multiple Sclerosis: Insights from Real-world Data Yasemin Şimşek, Zuhal Abasıyanık, Ulvi Samadzade, Serkan Ozakbas     Multiple Sclerosis JournalVolume 30, Issue 3_suppl: 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 18-20 September 2024, Copenhagen, Denmark
• Physical and Clinical Condition in People with Multiple Sclerosis Recovering from COVID-19 Serkan Ozakbas1, Ipek Yavas, Sinem Ozcelik, Ulvi Samadzade, SEDA DASTAN Multiple Sclerosis JournalVolume 29, Issue 3_suppl: MSMilan2023
• Impact of disability level and disease duration on cognitive functions in a large sample of people with multiple sclerosis: Which is the influencing factor? Pinar Yigit, Zuhal Abasıyanık, Ulvi Samadzade, Özge Sağıcı, Cavid Baba, Serkan Ozakbas Multiple Sclerosis JournalVolume 29, Issue 3_suppl: MSMilan2023 (P1090/2127)
• Cognitive impairment is associated with chronic neuropathic pain Hilal Karakas, Asiye Tuba Özdoğar, Özge Sağıcı, Ulvi Samadzade, Turhan Kahraman4, Serkan Ozakbas Multiple Sclerosis JournalVolume 29, Issue 3_suppl: MSMilan2023 (P1147/2137)
• Pregnancy, breastfeeding, and multiple sclerosis: what are the attitudes of women's Yasemin Şimşek, Ulvi Samadzade, Asiye Tuba Özdoğar, Serkan Ozakbas Multiple Sclerosis JournalVolume 29, Issue 3_suppl: MSMilan2023 (P1665/3196)